In clinical trials, one of the biggest risks isn’t always visible.
It’s not logistics.
It’s not the molecule.
It’s patient adherence.
Because no matter how promising a therapy is, if patients don’t follow the protocol correctly, the data (and ultimately the outcome of the study) can be compromised.
And yet, measuring adherence is far from straightforward.
When data doesn’t reflect reality
Clinical teams have long relied on tools like patient diaries or pill counts. But these often tell an incomplete story.
It’s not uncommon for reported adherence to conflict with pharmacokinetic measurements in blood samples. In simple terms: what patients say they did doesn’t always match what actually happened.
The result is uncertainty.
And in many cases, the workaround is costly – over-enrolling patients, extending timelines, or accepting a degree of risk in the data.
A solution that changes the rules, but not the communication challenge
Smart packaging was developed to solve exactly this problem.
By tracking medication usage in real time (from bottle openings to individual doses) these systems provide a level of visibility that traditional methods simply can’t match.
They transform adherence from something estimated… into something measurable.
But while the scientific value is clear, the communication challenge remains.
Because smart packaging isn’t a single product.
It’s a system.
It sits at the intersection of:
- patient behavior
- connected devices
- real-time data
- clinical decision-making
And most of what it does is invisible.
Where communication becomes critical
This is the point where many life science innovations slow down; not because they lack value, but because they are difficult to explain across different audiences.
What makes sense for a clinical operations team may not resonate the same way with business stakeholders, partners or decision-makers evaluating implementation.
And this is where specialized communication becomes essential.
Translating this kind of system requires more than simplifying language. It requires understanding the science well enough to reframe it without distorting it.
This is exactly where agencies like Transiris operate – at the intersection of science, strategy, and storytelling – often bringing together creative teams and scientific profiles (including PhDs) to ensure both clarity and credibility.
Turning complexity into something people can follow
For this project, the goal wasn’t to explain every feature.
It was to make the system intuitive.
The solution was a fully animated video that structures the story around a simple flow:
Small patient actions → generate data → create insight → enable intervention
Through animation, invisible processes become visible: how adherence is captured, how data moves, and how decisions are made in real time.
Instead of overwhelming the viewer, the narrative guides them (step by step) through a system that would otherwise remain abstract.
From system to significance
What emerges is not just a clearer explanation of a product, but a clearer understanding of its role.
Because smart packaging isn’t just about tracking medication.
It’s about:
- reducing uncertainty in trials
- improving data quality
- enabling faster, more confident decisions
And ultimately, improving outcomes.
Studies leveraging these solutions have shown up to a 20% increase in adherence – a meaningful shift in a context where small deviations can have major consequences.
From science to market
In life sciences, innovation doesn’t stop at discovery.
For it to create impact, it needs to be understood, trusted, and adopted.
And that transition (from complex science to real-world adoption) rarely happens on its own.
It requires translation.
The kind that keeps the science intact but makes it accessible to the people who need to act on it.
Because sometimes, the difference between a solution that exists and one that is actually used is how well it’s communicated.
